NVLPF (Nova Leap Health) 1-Year Sharpe Ratio: 0.53 (As of Jul. 12, 2026)


NVLPF Nova Leap Health Corp NVLPF
50 GF Score
Price $0.26
GF Value $0.23
Valuation Modestly Overvalued
! 1 Warning Sign
View Full Analysis

What is Nova Leap Health 1-Year Sharpe Ratio?

Nova Leap Health NVLPF 50 1-Year Sharpe Ratio is 0.53 as of Jul. 12, 2026. GuruFocus rates NVLPF with a GF Score™ of 50/100 and a GF Value™ of $0.23 (Modestly Overvalued). The stock has 1 warning sign investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-12), Nova Leap Health's 1-Year Sharpe Ratio is 0.53.

Nova Leap Health  (OTCPK:NVLPF) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

Nova Leap Health 1-Year Sharpe Ratio Related Terms

NVLPF vs HCA, THC, DVA: 1-Year Sharpe Ratio Comparison

For the Medical Care Facilities subindustry, Nova Leap Health's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nova Leap Health 1-Year Sharpe Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Nova Leap Health's 1-Year Sharpe Ratio falls into.


NVLPF
50GF Score
Nova Leap Health Corp NVLPF
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nova Leap Health 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 0.53 mean?
Nova Leap Health (NVLPF) has a 1-Year Sharpe Ratio of 0.53 as of Jul. 12, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Nova Leap Health and its competitors.
Is Nova Leap Health's 1-Year Sharpe Ratio too high?
Nova Leap Health's current 1-Year Sharpe Ratio is 0.53. Overall, Nova Leap Health has a GF Score™ of 50/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's 1-Year Sharpe Ratio compare to HCA and THC?
Nova Leap Health's 1-Year Sharpe Ratio of 0.53 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Healthcare Providers & Services company?
A good 1-Year Sharpe Ratio depends on the Healthcare Providers & Services industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Nova Leap Health and its competitors. Nova Leap Health's current 1-Year Sharpe Ratio is 0.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.23, compared to a current price of $0.26 — trading 13% above its estimated fair value. The current 1-Year Sharpe Ratio is 0.53. Nova Leap Health's overall GF Score™ is 50/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current 1-Year Sharpe Ratio is 0.53 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nova Leap Health (NVLPF) Overvalued in 2026?

Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued. The current stock price of $0.26 is trading 13% above its estimated GF Value™ of $0.23. GuruFocus considers Nova Leap Health to be Modestly Overvalued.

Key valuation signals for NVLPF:

  • 1-Year Sharpe Ratio: 0.53
  • GF Value™: $0.23 vs. price of $0.26 (13% above fair value)
  • GF Score™: 50/100 with 1 warning sign

No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nova Leap Health Business Description

Other Exchanges NLH:Canada
Address 7071 Bayers Road, Suite 3006, Halifax, NS, CAN, B3L 2C2
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
50GF Score

Get the complete analysis for NVLPF

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.26
Price
$0.23
GF Value